Crispr therapeutics CEO Samarth Kulkarni sells shares worth 1.67 million
| HHCZX Fund | USD 16.59 0.09 0.55% |
Slightly above 53% of Highland Long/short's investor base is interested to short. The analysis of overall sentiment of trading Highland Longshort Healthcare mutual fund suggests that many investors are impartial at this time. Highland Long/short's investing sentiment can be driven by a variety of factors including economic data, Highland Long/short's earnings reports, geopolitical events, and overall market trends.
Highland |
Crispr therapeutics CEO Samarth Kulkarni sells shares worth 1.67 million
Read at investing.com
 |
Highland Long/short Fundamental Analysis
We analyze Highland Long/short's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Highland Long/short using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Highland Long/short based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Last Dividend Paid
Last Dividend Paid Comparative Analysis
Highland Longshort is currently under evaluation in last dividend paid among similar funds. Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
Highland Long/short Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Highland Long/short mutual fund to make a market-neutral strategy. Peer analysis of Highland Long/short could also be used in its relative valuation, which is a method of valuing Highland Long/short by comparing valuation metrics with similar companies.
Peers
Highland Long/short Related Equities
| JGECX | Jhancock Global | 1.32 | ||||
| GMADX | Gmo Global | 1.16 | ||||
| QLENX | Aqr Long-short | 0.67 | ||||
| TRWIX | Transamerica International | 0.42 | ||||
| GTLSX | Quantitative | 0.36 | ||||
| ARTNX | Artisan Select | 0.48 | ||||
| MSTFX | Morningstar International | 0.63 |
Other Information on Investing in Highland Mutual Fund
Highland Long/short financial ratios help investors to determine whether Highland Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Highland with respect to the benefits of owning Highland Long/short security.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |